Lipopolysaccharide-induced blood brain barrier permeability is enhanced by alpha-synuclein expression

Neuroscience Letters

Volumn 551, Issue , 2013, Pages 23-27

  Jangula, Adam ^a   Murphy, Eric J ^a  

^a UNIVERSITY OF NORTH DAKOTA   (United States)

Author keywords

Synuclein; Blood brain barrier; Edema; Lipopolysaccharide; Snca

Indexed keywords

ALPHA SYNUCLEIN; EVANS BLUE; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN PERFUSION; BRAIN WATER; BRAIN WEIGHT; CENTRIFUGATION; CONTROLLED STUDY; EXTRAVASATION; FLUORESCENCE SPECTROSCOPY; HEMISPHERE; MALE; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPECTROFLUOROMETRY;

BLOOD-BRAIN BARRIER; EDEMA; LIPOPOLYSACCHARIDE; SNCA; Α-SYNUCLEIN;

ALPHA-SYNUCLEIN; ANIMALS; BLOOD-BRAIN BARRIER; CAPILLARY PERMEABILITY; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, KNOCKOUT;

EID: 84882274832     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.06.058     Document Type: Article

References (57)

1. Abbott N.J. Inflammatory mediators and modulation of blood-brain barrier permeability. Cellular and Molecular Neurobiology 2000, 20:131-147.
2. Abbott N.J., Patabendige A.A.K., Dolman D.E.M., Yusof S.R., Begley D.J. Structure and function of the blood-brain barrier. Neurobiology of Disease 2010, 37(1):13-25.
3. Ahn M., Kim S.B., Kang M., Ryu Y., Kim T.D. Chaperone-like activities of α-synuclein: α-synuclein assists enzyme activities of esterases. Biochemical and Biophysical Research Communications 2006, 346:1142-1149.
4. Argaw A.T., Zhang Y., Snyder B.J., Zhao M.-L., Kopp N., Lee S.C., Raine C.S., Brosnan C.F., John G.R. IL-1β regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program. Journal of Immunology 2006, 177:5574-5584.
5. Austin S.A., Floden A.M., Murphy E.J., Combs C.K. α-Synuclein expression modulates microglial activation phenotype. Journal of Neuroscience 2006, 26(4):10558-10563.
6. Austin S.A., Rojanathammanee L., Golovko M.Y., Murphy E.J., Combs C.K. Lack of alpha-synuclein modulates microglial phenotype in vitro. Neurochemical Research 2011, 36:994-1004.
7. Ay I., Francis J.W., Brown R.H. VEGF increases blood-brain barrier permeability to Evans blue dye and tetanus toxin fragment C but not adeno-associated virus in ALS mice. Brain Research 2008, 1234:198-205.
8. Barceló-Coblijn G., Golovko M.Y., Weinhofer I., Berger J., Murphy E.J. Brain neutral lipids mass is increased in α-synuclein gene-ablated mice. Journal of Neurochemistry 2007, 101:132-141.
9. Blais V., Turrin N.P., Rivest S. Cyclooxygenase 2 (COX-2) inhibition increases the inflammatory response in the brain during systemic immune stimuli. Journal of Neurochemistry 2005, 95:1563-1574.
10. Cabin D.E., Shimazu K., Murphy D., Cole N.B., Gottschalk W., McIlwain K.C., Orrison B., Chen A., Ellis C.E., Paylor R., Lu B., Nussbaum R.L. Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking α-synuclein. Journal of Neuroscience 2002, 22(20):8797-8807.
11. Castagnet P.I., Golovko M.Y., Barceló-Coblijn G., Nussbaum R.L., Murphy E.J. Fatty acid incorporation is decreased in astrocytes cultured from α-synuclein gene-ablated mice. Journal of Neurochemistry 2005, 94(3):839-849.
12. del Zoppo G.J., Milner R. Integrin-matrix interactions in the cerebral microvasculature. Arteriosclerosis, Thrombosis, and Vascular Biology 1975, 26:1966-1975.
13. Dempsey R.J., Baskaya M.K., Dogan A. Attenuation of brain edema, blood-brain barrier breakdown, and injury volume by Ifenprodil, a polyamine-site N-methyl-d-aspartate receptor antagonist, after experimental traumatic brain injury in rats. Neurosurgery 2000, 47(2):399-406.
14. Ellis C.E., Murphy E.J., Mitchell D.C., Golovko M.Y., Scaglia F., Barceló-Coblijn G., Nussbaum R.L. Mitochondrial lipid abnormality and electron transport chain impairment in mice lacking α-synuclein. Molecular and Cellular Biology 2005, 25(22):10190-10201.
15. 2. Stroke 1977, 8:480-483.
16. Engelhardt B., Sorokin L. The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction. Seminars in Immunopathology 2009, 31:497-511.
17. Fukui S., Fazzina G., Amorini A.M., Dunbar J.G., Marmarous A. Differential effects of atrial natriuretic peptide on the brain water and sodium after experimental cortical contusion in the rat. Journal of Cerebral Blood Flow and Metabolism 2003, 23:1212-1218.
18. Ghezzi P., Sacco S., Agnello D., Marullo A., Caselli G., Bertini R. LPS induces IL-6 in the brain and in serum largely through TNF production. Cytokine 2000, 12(8):1205-1210.
19. Godbout J.P., Berg B.M., Kelley K.W., Johnson R.W. α-Tocopherol reduces lipopolysaccharide-induced peroxide radical formation and interleukin-6 secretion in primary murine microglia and in brain. Journal of Neuroimmunology 2004, 149:101-109.
20. Golovko M.Y., Barceló-Coblijn G., Castagnet P.I., Austin S., Combs C.K., Murphy E.J. The role of alpha-synuclein in brain lipid metabolism: a downstream impact on brain inflammatory response. Molecular and Cellular Biochemistry 2009, 326(1-2):55-66.
21. Golovko M.Y., Færgeman N.J., Cole N.B., Castagnet P.I., Nussbaum R.L., Murphy E.J. α-Synuclein gene-deletion decreases brain palmitate uptake and alters the palmitate metabolism in the absence of α-synuclein palmitate binding. Biochemistry 2005, 44(23):8251-8259.
22. Golovko M.Y., Murphy E.J. Brain prostaglandin formation is increased by α-synuclein gene-ablation during global ischemia. Neuroscience Letters 2008, 432:243-247.
23. Golovko M.Y., Rosenberger T.A., Færgeman N.J., Feddersen S., Cole N.B., Pribill I., Berger J., Nussbaum R.L., Murphy E.J. Acyl-CoA synthetase activity links wild-type but not mutant α-synuclein to brain arachidonate metabolism. Biochemistry 2006, 45:6956-6966.
24. Golovko M.Y., Rosenberger T.A., Feddersen S., Færgeman N.J., Murphy E.J. α-Synuclein gene ablation increases docosahexaenoic acid incorporation and turnover in brain phospholipids. Journal of Neurochemistry 2007, 101:201-211.
25. Haring H.-P., Akamine P., Habermann R., Koziol J.A., del Zoppo G.J. Distribution of integrin-like immunoreactivity on primate brain microvasculature. Journal of Neuropathology and Experimental Neurology 1996, 55(2):236-245.
26. Henry C.J., Huang Y., Wynne A.M., Godbout J.P. Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1β and anti-inflammatory IL-10 cytokines. Brain, Behavior, and Immunity 2009, 23:309-317.
27. 2 formation parallels blood-brain barrier disruption in an experimental rat model of bacterial meningitis. Brain Research Bulletin 1998, 46(6):541-546.
28. Lv S., Song H.-L., Zhou Y., Li L.-X., Cui W., Wang W., Liu P. Tumour necrosis factor-α affects blood-brain barrier permeability and tight junction-associated occludin in acute liver failure. Liver International 2010, 30:1198-1210.
29. Meredith J.E., Fazeli B., Schwartz M.A. The extracellular matrix as a cell survival factor. Molecular Biology of the Cell 1993, 4:953-961.
30. Methia N., André P., Hafezi-Moghadam A., Economopoulos M., Thomas K.L., Wagner D.D. ApoE deficiency compromises the blood brain barrier especially after injury. Molecular Medicine 2001, 7(12):810-815.
31. Milner R., Hung S., Wang X., Berg G.I., Spatz M., del Zoppo G.J. Responses of endothelial cell and astrocyte matrix-integrin receptors to ischemia mimic those observed in the neurovascular unit. Stroke 2008, 39:191-197.
32. Mitic L.L., Anderson J.M. Molecular architecture of tight junctions. Annual Review of Physiology 1998, 60:121-142.
33. Mori F., Tanji K., Yoshimoto M., Takahashi H., Wakabayashi K. Demonstration of α-synuclein immunoreactivity in neuronal and glial cytoplasm in normal human brain tissue using proteinkinase K and formic acid pretreatment. Experimental Neurology 2002, 176:98-104.
34. Nedrebø T., Reed R.K. Different serotypes of endotoxin (lipopolysaccharide) cause different increases in albumin extravasation in rats. Shock 2002, 18(2):138-141.
35. Nonaka N., Shioda S., Banks W.A. Effect of lipopolysaccharide on the transport of pituitary adenylate cyclase activating polypeptide across the blood-brain barrier. Experimental Neurology 2005, 191:137-144.
36. Papadopoulos D., Ewans L., Pham-Dinh D., Knott J., Reynolds R. Upregulation of α-synuclein in neurons and glia in inflammatory demyelinating disease. Molecular and Cellular Neurosciences 2006, 31:597-612.
37. Paulus W., Baur I., Schuppan D., Roggendorf W. Characterization of integrin receptors in normal and neoplastic human brain. American Journal of Pathology 1993, 143(1):154-163.
38. Perez R.G., Waymire J.C., Lin E., Liu J.J., Guo F., Zigmond M.J. A role for α-synuclein in the regulation of dopamine biosynthesis. Journal of Neuroscience 2002, 22(8):3090-3099.
39. Persidsky Y., Ramirez S.H., Haorah J., Kanmogne G.D. Blood-brain barrier: structure of components and function under physiologic and pathologic conditions. Journal of Neuroimmune Pharmacology 2006, 1:223-236.
40. Pickard J.D., Macdonell L.A., Mackenzie E.T., Harper A.M. Prostaglandin-induced effects in the primate cerebral circulation. European Journal of Pharmacology 1977, 43:343-351.
41. Qin L., Wu X., Block M.L., Liu Y., Breese G.R., Hong J.-S., Knapp D.J., Crews F.T. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 2007, 55:453-462.
42. Quan N. Immune-to-brain signaling: how important are the blood-brain barrier-independent pathways?. Molecular Neurobiology 2008, 37:142-152.
43. Reisenauer C.J., Bhatt D.P., Mitteness D.J., Slanczka E.R., Gienger H.M., Watt J.A., Rosenberger T.A. Acetate supplementation attenuates lipopolysaccharide-induced neuroinflammation. Journal of Neurochemistry 2011, 117:264-274.
44. Rojanathammanee L., Murphy E.J., Combs C.K. Expression of mutant alpha-synuclein modulates microglial phenotype in vitro. Journal of Neuroinflammation 2011, 8(44):1-12.
45. Rosenberger T.A., Villacreses N.E., Hovda J.T., Boestti F., Weerasinghe G., Wine R.N., Harry G.J., Rapoport S.I. Rat brain arachidonic acid metabolism is increased by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide. Journal of Neurochemistry 2004, 88:1168-1178.
46. Salkeni M.A., Lynch J.L., Otamis-Price T., Banks W.A. Lipopolysaccharide impairs blood-brain barrier P-glycoprotein function in mice through prostaglandin- and nitric oxide-independent pathways. Journal of Neuroimmune Pharmacology 2009, 4:276-282.
47. Sharon R., Goldberg M.S., Bar-Josef I., Betensky R.A., Shen J., Selkoe D.J. α-Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins. Proceedings of the National Academy of Science of the United States of America 2001, 98(16):9110-9115.
48. Slivka A.P., Murphy E.J., Horrocks L.A. Cerebral edema after temporary and permanent middle cerebral artery occlusion in the rat. Stroke 1995, 26:1061-1065.
49. Stolp N.B., Dziegielewska K.M. Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases. Neuropathology and Applied Neurobiology 2009, 35:132-146.
50. Tagaya M., Haring H.-P., Stuiver I., Wagner S., Abumiya T., Lucero J., Lee P., Copeland B.R., Seiffert D., del Zoppo G.J. Rapid loss of microvascular integrin expression during focal brain ischemia reflects neuron injury. Journal of Cerebral Blood Flow and Metabolism 2001, 21:835-846.
51. Uyama O., Okamura N., Yanase M., Narita M., Kawabata K., Sugita M. Quantitative evaluation of vascular permeability in the gerbil brain after transient ischemia using Evans blue fluorescence. Journal of Cerebral Blood Flow and Metabolism 1988, 8:282-284.
52. Verma S., Nakaoke R., Dohgu S., Banks W.A. Release of cytokines by brain endothelial cells: a polarized response to lipopolysaccharide. Brain, Behavior, and Immunity 2006, 20:449-455.
53. Wersinger C., Sidhu A. Attenuation of dopamine transporter activity by α-synuclein. Neuroscience Letters 2003, 340:189-192.
54. Willard L.B., Hauss-Wegrzyniak B., Wenk G.L. Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats. Neuroscience 1999, 88(1):193-200.
55. Wispelwey B., Lesse A.J., Hansen E.J., Scheld W.M. Haemophilus influenzae lipopolysaccharide-induced blood-brain barriers permeability during experimental meningitis in the rat. Journal of Clinical Investigation 1988, 82(4):1339-1346.
56. Xaio H., Banks W.A., Niehoff M.L., Morley J.E. Effect of LPS on the permeability of the blood-brain barrier to insulin. Brain Research 2001, 896:36-42.
57. Yamamoto Y.L., Feindel W., Wolfe L.S., Katoh H., Hodge C.P. Experimental vasoconstriction of cerebral arteries by prostaglandins. Journal of Neurosurgery 1972, 37:385-397.